Gastrointestinal Eosinophilic Disorder in a Patient with Acute Pancreatitis. Case Report
Main Article Content
Abstract
Eosinophilic colitis is a rare disease. It is part of the eosinophilic gastroenteritis, characterized by eosinophilic infiltration of the tissues that affects any segment of the digestive tract, but more frequently the stomach and small intestine and rarely the colon in isolation. The clinical case of a 29- year-old patient is described, who initially presented data of acute pancreatitis and later acute diarrhea with sluggishness and scant mucus. The analysis showed a complete blood count with eosinophilia 9.9% Immunoglobulin E with a positive result + 2500 IU/mL (<100IU/mL). Endoscopy and colonoscopies show diffuse inflammatory changes, confirming with the histopathological study infiltration of eosinophils throughout the gastrointestinal tract, conservative treatment was started with a good response. Eosinophilic gastroenteritis has a benign course, with significant infiltration of eosinophils in the wall of the digestive tract, which rarely involves only the colon. Its cause and pathogenic mechanisms are unknown; It classically presents in patients between the third and fifth decades of life, although it can affect any age group. The diagnostic criteria are: 1) gastrointestinal symptoms; 2) eosinophilic infiltration of one or more areas of the digestive tract demonstrated by biopsy; 3) absence of eosinophilic infiltration in organs outside the digestive tract; and 4) absence of parasitic infection. Eosinophilic gastroenteritis are pathologies that require a high index of suspicion for their diagnosis.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Chen PH, Anderson L, Zhang K, Weiss GA. (2021). Eosinophilic gastritis/gastroenteritis. Current Gastroenterology Reports, 23(8), 13.
II. Jackson, H. (1978). Eosinophilic gastroenteritis: Epidemiology, diagnosis, and treatment. New York State Journal of Medicine, 78(13), 2075–2077.
III. Gonsalves N. Eosinophilic gastrointestinal disorders. Clinical Reviews in Allergy & Immunology, 57(2), 272–285.
IV. Kinoshita Y, Oouchi S, Fujisawa T. Eosinophilic gastrointestinal diseases - Pathogenesis, diagnosis, and treatment. Allergology International: Official Journal of the Japanese Society of Allergology, 68(4), 420–429.
V. Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol. 2019;12:239-253
VI. Turner PJ, Tang MLK, Wood RA. Food Allergy and Eosinophilic Gastrointestinal Diseases-The Next 10 Years. The journal of allergy and clinical immunology. In practice, 11(1), 72–78.
VII. Kinoshita Y, Yahata S, Oouchi S. Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment. Internal medicine (Tokyo, Japan), 62(1), 1–10.
VIII. O'Sullivan JA, Bochner BS. Eosinophils and eosinophil-associated diseases: An update. The Journal of allergy and clinical immunology, 141(2), 505–517.
IX. Uppal V, Kreiger P, Kutsch E. Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review. Clinical reviews in allergy & immunology, 50(2), 175–188.
X. Oyaizu, N, Uemura Y, Izumi, H, Morii S, Nishi M, Hioki K. Eosinophilic gastroenteritis. Immunohistochemical evidence for IgE mast cell-mediated allergy. Acta pathologica japonica, 35(3), 759– 766.
XI. Jensen ET, Dellon ES. Environmental factors and eosinophilic esophagitis. The Journal of allergy and clinical immunology, 142(1), 32–40.
XII. Jensen ET, Kuhl JT, Martin LJ, Rothenberg ME, Dellon ES. Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2018;141(1):214-222.
XIII. Untersmayr E, Bakos N, Schöll I, et al. Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J. 2005;19(6):656-658.
XIV. Schöll IP, Jarolim EJ. Anti-acid medication as a risk factor for food allergy. Allergy, 66(4), 469–477.
XV. Rothenberg ME, Spergel JM, Sherrill JD, AnnaiahK, Martin LJ, Cianferoni, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nature genetics, 42(4), 289–291.
XVI. Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nature genetics, 46(8), 895–900.
XVII. Sleiman P, Wang ML, Cianferoni A. et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun 5, 5593 (2014).
XVIII. Kinoshita Y, Ishimura N, Oshima N, Ishihara S. Systematic review: Eosinophilic esophagitis in Asian countries. World journal of gastroenterology, 21(27), 8433–8440.
XIX. Yamamoto M, Nagashima S, Yamada Y, Murakoshi T, Shimoyama Y, Takahashi S. Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey. The journal of allergy and clinical immunology. In practice, 9(9), 3339–3349.e8.
XX. Kinoshita Y, Furuta K, Ishimaura N, Ishihara S, Sato S., Maruyama R, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. Journal of gastroenterology, 48(3), 333–339.
XXI. Ishimura N, Furuta K, Sato S, Ishihara S, Kinoshita Y. Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders. Journal of gastroenterology and hepatology, 28(8), 1306–1313.
XXII. Subbarao G, Rosenman MB, OhnukiL, Georgelas A, Davis M, Fitzgerald, J. F, et al. Exploring potential noninvasive biomarkers in eosinophilic esophagitis in children. Journal of pediatric gastroenterology and nutrition, 53(6), 651–658.
XXIII. Mehta P, Furuta GT. Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunology and allergy clinics of North America, 35(3), 413–437.
XXIV. Steinbach EC, Hernandez M, Dellon ES. Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management. The journal of allergy and clinical mmunology. In practice, 6(5), 1483–1495.
XXV. Sylva D, Tamayo L, Mosquera-Klinger G, Carvajal JJ, Pérez JC. Eosinophilic gastroenteritis: An unusual presentation of a rare disease. Gastroenteritis eosinofílica: presentación inusual de una enfermedad poco común. Revista de gastroenterologia de Mexico (English), 84(1), 116–118.
XXVI. Vargas OMG, Candía DS, Ramírez EC, Vázquez MIC, Camaño MEV, Acosta GR, et al. Gastroenteritis eosinofílica [Eosinophilic gastroenteritis]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico: 1993), 61(3), 212–218.
XXVII. Aguilar GA, Aguilar GA, Arias, FR,Trigueros JAL, Carrillo GD. Gastroenteritis eosinofílica. Recuperado el 24 de mayo de 2023, de Medigraphic.com website: https://www.medigraphic.com/pdfs/actmed/am-2015/am154e.pdf
XXVIII. Rodríguez M, Roberto B, María A, González I, Torregroza G. Desórdenes eosinofílicos gastrointestinales (DEGI): presentación de dos casos. Revista colombiana de Gastroenterología, 22(2), 138-148.
XXIX. Shimura S, Ishimur N, Tanimura T, Yuki T, Miyake T, Kushiyama Y. Reliability of symptoms and endoscopic findings for diagnosis of esophageal eosinophilia in a Japanese population. Digestion, 90(1), 49–57.
XXX. Jiao D, Ishimura N, Maruyama R, Ishikawa N, Nagase M, Oshima N, et al. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
XXXI. Hui CK, Hui NK. A Prospective Study on the Prevalence, Extent of Disease and Outcome of Eosinophilic Gastroenteritis in Patients Presenting with Lower Abdominal Symptoms. Gut and liver, 12(3), 288–296.
XXXII. Pesek RD, Reed CC, Collins MH, Muir AB, Fulkerson PC, Katcher SM, et al. Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (2020). Association between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders. Digestive diseases and sciences, 65(7), 2024–2035.
XXXIII. DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME. Quantity and Distribution of Eosinophils in the Gastrointestinal Tract of Children. Pediatric and Developmental Pathology. 2006;9(3):210-218.
XXXIV. Lowichik A, Weinberg A. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 9 2, 110-4 .
XXXV. Dellon ES. Eosinophilic esophagitis: diagnostic tests and criteria. Current opinion in gastroenterology, 28(4), 382–388.
XXXVI. Lee S, Boer WB, Naran A, Leslie C, Raftopoulous SE, Kumarasinghe, M. P. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. Journal of clinical pathology, 63(7), 644–647.
XXXVII. Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Advances in anatomic pathology, 18(5), 335–348.
XXXVIII. Uppal V, Kreiger P, Kutsch E. Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review. Clinical reviews in allergy & immunology, 50(2), 175–188.
XXXIX. Lee J, Dierkhising R, Wu TT, Alexander, J., & Weiler, C. (2011). Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Digestive diseases and sciences, 56(11), 3254–3261.
XL. Gonsalves, N., Yang, G. Y., Doerfler, B., Ritz, S., Ditto, A. M., & Hirano, I. (2012). Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology, 142(7), 1451–e15.
XLI. Siewert E, Lammert F, Koppitz P, Schmidt T, Matern S. Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 38(1), 55–59.
XLII. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut, 59(1), 21–30.